RT @RBPatelMD: 👇Effects of SGLT1 vs 2 inhibition: is there an added benefit? @abavishi23 has shown that a functionally modifying variant…
RT @RBPatelMD: 👇Effects of SGLT1 vs 2 inhibition: is there an added benefit? @abavishi23 has shown that a functionally modifying variant…
RT @RBPatelMD: 👇Effects of SGLT1 vs 2 inhibition: is there an added benefit? @abavishi23 has shown that a functionally modifying variant…
👇Effects of SGLT1 vs 2 inhibition: is there an added benefit? @abavishi23 has shown that a functionally modifying variant of SLC5A1➡️better LV systolic fxn: https://t.co/AYRREoB2tw This variant protects from⬆️glucose: https://t.co/APDj7XC29a A sequel
RT @MacroFour: Mendelian Randomisation shows that defective glucose gut absorption roughly halves your risk of heart failure, diabetes, obe…
Mendelian Randomisation shows that defective glucose gut absorption roughly halves your risk of heart failure, diabetes, obesity, & death. Yet we are told (without good evidence?) that emulatory low glucose/ starch (LC) diets shorten life. H/T @puddl
@MacroFour This Seidelmann study? https://t.co/Vzi860g3M7
@singhak_endo You can start with this paper in @JACCJournals: https://t.co/bdVd4t3U8B
@ethanjweiss Interesting that genetic variants in humans with lower SGLT1 and/or SGLT2 activity decreases risk of not only obesity, diabetes but also heart failure and death: https://t.co/v2bE8RVYZV
RT @Karageorgos15: Decreasing glucose absorption from gut or decreasing glucose re-absorption from kidneys due to genetic variants that lea…
Decreasing glucose absorption from gut or decreasing glucose re-absorption from kidneys due to genetic variants that lead to loss of SLGT 1 and/or SLGT 2 function appears to significantly decrease incidence of DM, HF, and/or all-cause mortality: https://t
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
@DrKanupp @vegansie @EricTopol @ProfTimNoakes @JAMAInternalMed @sjoshimd @Veg_MD Here's another line of evidence - genetic and drug. Genes and drugs (acarbose, metformin) that reduce absorption of glucose (lower carb exposure) are protective against CVD, o
RT @PreKureOfficial: Reduced intestinal glucose uptake may protect from long-term cardiometabolic outcomes - obesity, diabetes, heat failur…
RT @PreKureOfficial: Reduced intestinal glucose uptake may protect from long-term cardiometabolic outcomes - obesity, diabetes, heat failur…
RT @PreKureOfficial: Reduced intestinal glucose uptake may protect from long-term cardiometabolic outcomes - obesity, diabetes, heat failur…
RT @PreKureOfficial: Reduced intestinal glucose uptake may protect from long-term cardiometabolic outcomes - obesity, diabetes, heat failur…
RT @PreKureOfficial: Reduced intestinal glucose uptake may protect from long-term cardiometabolic outcomes - obesity, diabetes, heat failur…
Reduced intestinal glucose uptake may protect from long-term cardiometabolic outcomes - obesity, diabetes, heat failure, and death (HR: 0.66; 95% CI: 0.42 to 0.90). The Seidelmann et al, 2018 paper that didn't make it into the mainstream media - go figure.
RT @JACCJournals: Association of Genetic Variants Related to SGLT1 Inhibition with Glucose Tolerance and Cardiometabolic Risk was the 2️⃣nd…
RT @JACCJournals: Association of Genetic Variants Related to SGLT1 Inhibition with Glucose Tolerance and Cardiometabolic Risk was the 2️⃣nd…
RT @JACCJournals: Association of Genetic Variants Related to SGLT1 Inhibition with Glucose Tolerance and Cardiometabolic Risk was the 2️⃣nd…
RT @JACCJournals: Association of Genetic Variants Related to SGLT1 Inhibition with Glucose Tolerance and Cardiometabolic Risk was the 2️⃣nd…
RT @JACCJournals: Association of Genetic Variants Related to SGLT1 Inhibition with Glucose Tolerance and Cardiometabolic Risk was the 2️⃣nd…
RT @JACCJournals: Association of Genetic Variants Related to SGLT1 Inhibition with Glucose Tolerance and Cardiometabolic Risk was the 2️⃣nd…
Association of Genetic Variants Related to SGLT1 Inhibition with Glucose Tolerance and Cardiometabolic Risk was the 2️⃣nd most popular #JACC podcast last year! Listen here: https://t.co/KUOMt0SFtQ. https://t.co/OUfvdFAlVn
RT @Karageorgos15: @Mangan150 Interestingly certain people with genetic variants in SGLT1 that lead to decrease intestinal absorption of gl…
RT @Karageorgos15: @Mangan150 Interestingly certain people with genetic variants in SGLT1 that lead to decrease intestinal absorption of gl…
@Mangan150 Interestingly certain people with genetic variants in SGLT1 that lead to decrease intestinal absorption of glucose also show lower obesity, diabetes, heart failure and mortality: https://t.co/igm9Chp8JT
RT @Karageorgos15: @eatmostlyfatali @JeffryGerberMD @FatEmperor @KetoCarnivore @ChristianAssad Interesting that genetic variants in humans…
RT @Karageorgos15: @eatmostlyfatali @JeffryGerberMD @FatEmperor @KetoCarnivore @ChristianAssad Interesting that genetic variants in humans…
RT @Karageorgos15: @eatmostlyfatali @JeffryGerberMD @FatEmperor @KetoCarnivore @ChristianAssad Interesting that genetic variants in humans…
@eatmostlyfatali @JeffryGerberMD @FatEmperor @KetoCarnivore @ChristianAssad Interesting that genetic variants in humans with lower SGLT2 and SGLT1 activity decreases risk of obesity, diabetes and prolongs life. So decreasing the absorption of glucose from
Why is it that, despite consuming the same number of calories, some people face little risk of diabetes or obesity while others are at higher risk? In @JACCJournals: characterizing a gene variant that may affect obesity, diabetes and heart failure. https:/
RT @gabrielsteg: Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidenc…
RT @gabrielsteg: Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidenc…
RT @gabrielsteg: Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidenc…
RT @gabrielsteg: Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidenc…
RT @gabrielsteg: Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidenc…
RT @gabrielsteg: Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidenc…
RT @gabrielsteg: Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidenc…
RT @gabrielsteg: Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidenc…
RT @gabrielsteg: Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidenc…
RT @gabrielsteg: Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidenc…
RT @gabrielsteg: Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidenc…
Interesting paper in JACC using a mendelian randomization approach and suggesting that SGLT1 inhibition may lower incidence of diabetes, heart failure and obesity. Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk https://t.co/rGGMWxJo
Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk @DanielJDrucker https://t.co/gLzvWPZZku
Falls mal wieder jemand behauptet, es gebe gar keinen KAUSALEN Zusammenhang von Zuckeraufnahme und Adipositas/Diabetes/Herzerkrankungen - hier ist der Beweis: https://t.co/ceuome6kMy
In @JACCJournals: New research shows SGLT1 mutations protect from hyperglycemia, may protect from long-term cardiometabolic outcomes https://t.co/OkI4K5fMFH
RT @IlindelatorreMD: A menor captación intestinal de glucosa, menor riesgo de alteraciones cardiometabólicas (obesidad, diabetes, fallo car…
RT @IlindelatorreMD: A menor captación intestinal de glucosa, menor riesgo de alteraciones cardiometabólicas (obesidad, diabetes, fallo car…
https://t.co/3yGQUQdQey Lean, lean
RT @IlindelatorreMD: A menor captación intestinal de glucosa, menor riesgo de alteraciones cardiometabólicas (obesidad, diabetes, fallo car…
RT @IlindelatorreMD: A menor captación intestinal de glucosa, menor riesgo de alteraciones cardiometabólicas (obesidad, diabetes, fallo car…
RT @IlindelatorreMD: A menor captación intestinal de glucosa, menor riesgo de alteraciones cardiometabólicas (obesidad, diabetes, fallo car…
RT @pronutritionist: Some of us have incomplete absorption of glucose due to their atypical genes and consequently seem to have ↓ risk of t…
RT @IlindelatorreMD: A menor captación intestinal de glucosa, menor riesgo de alteraciones cardiometabólicas (obesidad, diabetes, fallo car…
RT @IlindelatorreMD: A menor captación intestinal de glucosa, menor riesgo de alteraciones cardiometabólicas (obesidad, diabetes, fallo car…
A menor captación intestinal de glucosa, menor riesgo de alteraciones cardiometabólicas (obesidad, diabetes, fallo cardíaco, etc). https://t.co/FflIfNmAsn
Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk https://t.co/bENsnc5PDS
Researchers has discovered one genetic variant that slows the metabolism of sugar in the gut providing people with the mutation protection against diabetes, obesity and heart disease. Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk
Human SGLT1 variant reduces glucose uptake and Lowers disease risk and mortality https://t.co/fxSV04Eg6m
Functionally damaging missense variants in SGLT1 protect from diet-induced hyperglycemia in multiple populations. Reduced intestinal glucose uptake may protect from long-term cardiometabolic outcomes - https://t.co/n1dMqEXnAH
Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk https://t.co/wHFUG2KLdg #diabetes research
Mutaciones en SGLT1 (asociado a la absorción deteriorada de la glucosa) se liga a un menor riesgo de obesidad, de diabetes, falla cardíaca y de mortalidad, aun con ingesta de energía total elevada. La genética humana y fisiología https://t.co/zB9HYfeFXJ
RT @JACCJournals: What are the clinical consequences of damaging mutations of SGLT1? https://t.co/QQWYzoTFak #JACC https://t.co/aI7LrLuRYs
RT @JACCJournals: What are the clinical consequences of damaging mutations of SGLT1? https://t.co/QQWYzoTFak #JACC https://t.co/aI7LrLuRYs
Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk. https://t.co/eKatg61MGv
Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk https://t.co/6tGNaU8qTr Important research on #metabolic syndrome
RT @JACCJournals: What are the clinical consequences of damaging mutations of SGLT1? https://t.co/QQWYzoTFak #JACC https://t.co/aI7LrLuRYs
RT @JACCJournals: What are the clinical consequences of damaging mutations of SGLT1? https://t.co/QQWYzoTFak #JACC https://t.co/aI7LrLuRYs
What are the clinical consequences of damaging mutations of SGLT1? https://t.co/QQWYzoTFak #JACC https://t.co/aI7LrLuRYs
RT @krychtiukmd: SGLT-1 functionally damaging missense variants protect from diet-induced hyperglycemia - genetic base for combined SGLT-1…
Low frequency disruptive variants in SGTL1 are associated with reduced cardiometabolic risk https://t.co/ohx2ih2xxL @JACCJournals But homozygous genotypes of rare disruptive variants in SGTL1 linked to severe newborn diarrhea/dehydration https://t.co/j8Hll
RT @JACCJournals: Could SGLT1 inhibition reduce #obesity, DM2, CHF, and death? https://t.co/MkJgj4EcyE #JACC @BrighamWomens https://t.co/em…
RT @krychtiukmd: SGLT-1 functionally damaging missense variants protect from diet-induced hyperglycemia - genetic base for combined SGLT-1…
RT @JACCJournals: Could SGLT1 inhibition reduce #obesity, DM2, CHF, and death? https://t.co/MkJgj4EcyE #JACC @BrighamWomens https://t.co/em…
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
RT @JACCJournals: Could SGLT1 inhibition reduce #obesity, DM2, CHF, and death? https://t.co/MkJgj4EcyE #JACC @BrighamWomens https://t.co/em…
RT @JACCJournals: Could SGLT1 inhibition reduce #obesity, DM2, CHF, and death? https://t.co/MkJgj4EcyE #JACC @BrighamWomens https://t.co/em…
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
RT @JACCJournals: Could SGLT1 inhibition reduce #obesity, DM2, CHF, and death? https://t.co/MkJgj4EcyE #JACC @BrighamWomens https://t.co/em…
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
RT @JACCJournals: Could SGLT1 inhibition reduce #obesity, DM2, CHF, and death? https://t.co/MkJgj4EcyE #JACC @BrighamWomens https://t.co/em…
Could SGLT1 inhibition reduce #obesity, DM2, CHF, and death? https://t.co/MkJgj4EcyE #JACC @BrighamWomens https://t.co/emIJKkO16f
RT @pronutritionist: Some of us have incomplete absorption of glucose due to their atypical genes and consequently seem to have ↓ risk of t…
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
RT @pronutritionist: Some of us have incomplete absorption of glucose due to their atypical genes and consequently seem to have ↓ risk of t…
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
RT @pronutritionist: Some of us have incomplete absorption of glucose due to their atypical genes and consequently seem to have ↓ risk of t…
Very exciting!
RT @ArsenaultBenoit: LOF mutations in SGLT1 (associated with impaired glucose absorption) linked with lower risk of obesity, incident diabe…
RT @krychtiukmd: SGLT-1 functionally damaging missense variants protect from diet-induced hyperglycemia - genetic base for combined SGLT-1…